PP
VCYT icon

Paloma Partners’s Veracyte VCYT Stock Holding History

Paloma Partners’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8,542
Closed -$208K – 2252
2020
Q1 		$208K Buy
+8,542
New +$215K 0.01% 880
2019
Q4 		– Sell
-22,472
Closed -$539K – 2534
2019
Q3 		$539K Buy
+22,472
New +$598K 0.01% 1103

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Paloma Partners's VCYT Position: Q2 2020 in Review

Paloma Partners sold out of Veracyte (VCYT) in Q2 2020, closing a stake of 8,542 shares — an estimated $208K sold.

Paloma Partners first reported a position in VCYT in Q3 2019 and held it in 2 quarters. The position peaked at $539K in Q3 2019. 166 funds tracked by Wall St. Rank hold VCYT as of Q2 2020.

  • Paloma Partners reported no remaining Veracyte position as of Q2 2020 after selling out during the quarter.
  • Paloma Partners sold 8,542 Veracyte shares in Q2 2020, an estimated $208K.
  • Paloma Partners first reported a position in Veracyte in Q3 2019 and held it in 2 quarters.
  • Paloma Partners's Veracyte position peaked at $539K in Q3 2019.
  • 166 funds tracked by Wall St. Rank held Veracyte as of Q2 2020.

Based on Paloma Partners's 13F filing for Q2 2020, filed 14 Aug 2020.